Task: Answer the MCQ question.
Query: Which drug exhibits a -27.898% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Cn1c2ccccc2c2nnc(SCc3nnc(-c4ccccc4)o3)nc21
b.) Cc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(S(=O)(=O)N2CCCCCC2)c1
Answer: a. Cn1c2ccccc2c2nnc(SCc3nnc(-c4ccccc4)o3)nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c2ccccc2c2nnc(SCc3nnc(-c4ccccc4)o3)nc21
Cn1c2ccccc2c2nnc(SCc3nnc(-c4ccccc4)o3)nc21
2-[(5-methyl-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanylmethyl]-5-phenyl-1,3,4-oxadiazole